A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic Rhinitis

NCT00612118 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis
Rhinitis, Allergic, Seasonal

Interventions

DRUG: GSK256066
DRUG: azelastine hydrochloride

Sponsor

GlaxoSmithKline